MultiHance® (gadobenate dimeglumine) injection, 529 mg/mL Improves Visualization and Enhancement of Lesions vs. Dotarem® (gadoterate meglumine)1
Colosimo et al.
52-year-old woman with primary glioma
These are representative images from reference studies; individual results may vary.
Reference: 1. Colosimo C, Knopp MV, Barreau X, et al. A comparison of Gd-BOPTA and Gd-DOTA for contrast-enhanced MRI of intracranial tumours. Neuroradiology. 2004;46(8):655-665.
More cases that may interest you